Kristin Agopian, PhD
Assistant Director
Innovation Ventures
Chancellor/EVC/FAS
Kristin has been managing intellectual property and commercialization for UCSF since 2008. Her portfolio of technologies includes therapeutics, diagnostics, and medical devices. She works closely with UCSF faculty and staff to develop and commercialize their inventions, build large research collaboration and licensing partnerships, and spin out companies.
Show full bio (100 words) Hide full bio
In addition, she negotiates and drafts IP agreements including licenses, options, inter-institutional agreements, CDAs and MTAs.
Kristin holds a Ph.D. in Virology from Harvard University and an A.B. in Molecular Biology from Princeton University. She has hands-on research experience in HIV pathogenesis, cell signaling, cell biology, mouse genetics and Drosophila development and speciation. She also has experience in business strategy consulting in the biotechnology and pharmaceutical space and in science and technology policy at the National Academies.
Kristin is excited about helping UCSF researchers succeed in translation of their cutting edge research into technologies that will advance health worldwide.
Publications (5)
Top publication keywords:
Lymphoid TissueGene Products, nefVesicular Transport ProteinsReceptors, HIVHIV-1AIDS Dementia ComplexGenes, nefp21-Activated KinasesSequence AlignmentHydrophobic and Hydrophilic InteractionsHistocompatibility Antigens Class IAcquired Immunodeficiency SyndromeCD4 Antigensnef Gene Products, Human Immunodeficiency VirusAmino Acid Sequence
-
Proteomic analysis of HIV-1 Nef cellular binding partners reveals a role for exocyst complex proteins in mediating enhancement of intercellular nanotube formation.
Retrovirology 2012 Mukerji J, Olivieri KC, Misra V, Agopian KA, Gabuzda D -
Evidence for adaptive evolution at the divergence between lymphoid and brain HIV-1 nef genes.
AIDS research and human retroviruses 2010 Olivieri KC, Agopian KA, Mukerji J, Gabuzda D -
Changes in the V3 region of gp120 contribute to unusually broad coreceptor usage of an HIV-1 isolate from a CCR5 Delta32 heterozygote.
Virology 2007 Gorry PR, Dunfee RL, Mefford ME, Kunstman K, Morgan T, Moore JP, Mascola JR, Agopian K, Holm GH, Mehle A, Taylor J, Farzan M, Wang H, Ellery P, Willey SJ, Clapham PR, Wolinsky SM, Crowe SM, Gabuzda D -
CD4 and MHC-I downregulation are conserved in primary HIV-1 Nef alleles from brain and lymphoid tissues, but Pak2 activation is highly variable.
Virology 2006 Agopian K, Wei BL, Garcia JV, Gabuzda D -
A hydrophobic binding surface on the human immunodeficiency virus type 1 Nef core is critical for association with p21-activated kinase 2.
Journal of virology 2006 Agopian K, Wei BL, Garcia JV, Gabuzda D